With $100M in fresh backing and a new TCR initiative, Athenex launches China JV

A year after Johnson Lau outlined the full measure of his plans for a biotech comeback in an S-1 filing for Athenex $ATNX, the biotech exec has followed up with a $100 million investment/loan from Perceptive along with a new Chinese joint venture which will set out to engineer TCRs for cancer. The Buffalo-based company … Continue reading With $100M in fresh backing and a new TCR initiative, Athenex launches China JV